Combined Estrogen and Testosterone Use and Risk of Breast Cancer in Postmenopausal Women -
RM Tamimi, SE Hankinson, WY Chen, B Rosner, GA … - Archives of Internal Medicine, 2006 - Am Med Assoc
... Although this study had 56 breast cancer cases exposed to E&T therapy, the treatment
was ... Estratest was the primary E&T therapy reported by women in the present ...

Adult Weight Change and Risk of Postmenopausal Breast Cancer. -
AH Eliassen, GA Colditz, B Rosner, WC Willett, SE … - Obstetrical & Gynecological Survey, 2006 - obgynsurvey.com
... The planned use of HPV testing in programs screening for cervical cancer makes
this issue especially important. ... Epithelial Ovarian Cancer ...

… of esterified estrogens?methyltestosterone (Estratest? and Estratest? HS) replacement therapy in … -
E Phillips, C Bauman - Clinical Therapeutics, 1997 - Elsevier
... that was a drug over- dose, cancer, or a ... Body System and Preferred Term n (%) Estratest
HS n ... Lack of effect Headache Hostility Urogenital Breast pain Nervous ...

Does Estrogen plus Androgen Increase Risk for Breast Cancer?
RM Tamimi - Journal Watch Women's Health, 2006 - Mass Med Soc
... and methyltestosterone (Estratest). The 24-year follow-up spanned the period from
1978 to 2002, during which 4610 incident cases of invasive breast cancer were ...
-

Proportion of Invasive Breast Cancer Attributable to Risk Factors Modifiable after Menopause
BL Sprague, A Trentham-Dietz, KM Egan, L Titus- … - American Journal of Epidemiology, 2008 - Oxford Univ Press
... progestin only, Estratest (Solvay Pharmaceuticals, Marietta, Georgia)). A woman
was considered to have a first-degree family history of breast cancer if she ...

Estratest? and Estratest? HS (esterified estrogens and methyltestosterone) therapy: A summary of … -
EH Phillips, S Ryan, R Ferrari, C Green - Clinical Therapeutics, 2003 - Elsevier
... These concerns include endometrial cancer, breast cancer, and cardiovas- cular disease,
and ... This review summarizes the safety surveillance data for Estratest ...
-

It might be wise to consider adding androgen to the estrogen or estrogen-progestin regimens in the … -
MM Gelfand - Menopause, 2004 - menopausejournal.com
... The Estratest Working Group. J Womens Health 1996;5:593-602. ... Breast cancer incidence
with parenteral estradiol and testosterone replacement therapy [Abstract]. ...

Hormone Replacement Therapy: Where Do We Go Now? -
AM Kaunitz - Breast J, 2002 - Blackwell Synergy
... HRT, ERT, and ovarian cancer risk should ... Appropriate breast surveillance for women
50 years of ... or in combination with androgen (Estratest, Estratest HS) will ...
-

Hormone Replacement Therapy: Where Do We Go Now?
WHIFR COMBINATION, EP HRT - The Breast Journal, 2002 - ingentaconnect.com
... therapy, either estrogen alone or in combination with androgen (Estratest, Estratest
HS) will ... that the use of OCs does not increase breast cancer risk (3 ...
-

Use of Combination Hormone Replacement Therapy in Light of Recent Data From the Women's Health … -
AM Kaunitz - Medscape General Medicine, 2002 - medscape.com
... therapy, either estrogen alone or in combination with androgen (Estratest, Estratest
HS), will ... clarify that use of OCs does not increase breast cancer risk. ...